£90 MILLION of funding has been channelled into the development of a new cancer drug; known as a POLQ inhibitor, it specifically targets cancer cells with the mutated BRCA genes, while leaving healthy cells unharmed.
You Can See More: Cancer treatment: 'Exciting' new drug targets tumours created by faulty BRCA genes
The following article Cancer treatment: 'Exciting' new drug targets tumours created by faulty BRCA genes is courtesy of Daily Express :: Health Feed
£90 MILLION of funding has been channelled into the development of a new cancer drug; known as a POLQ inhibitor, it specifically targets cancer cells with the mutated BRCA genes, while leaving healthy cells unharmed.
£90 MILLION of funding has been channelled into the development of a new cancer drug; known as a POLQ inhibitor, it specifically targets cancer cells with the mutated BRCA genes, while leaving healthy cells unharmed.
Related Posts:
You Can See More: Pancreatic cancer: Does your urine and stools look like this? The hidden warning signs- You Can See More: Back pain: When your back pain could signal a vascular disorder – symptoms to spot
- You Can See More: Vitamin B12 deficiency: Is your hair beginning to look this way? Sign of the condition
- You Can See More: Best supplements for men: The mineral that could benefit men over the age of 50
- You Can See More: How to get rid of visceral fat: Adding certain seeds to your diet could help burn the fat
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.